Skip to main content
Clinical Trials/IRCT20230529058336N1
IRCT20230529058336N1RecruitingPhase 3

Evaluation of Efficacy of Botulinum Toxin In The Treatment Of Acne Vulgaris: A Double-Blind Clinical Trial

Tehran University of Medical Sciences0 sites30 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 55 years (—)
Sex
All

Inclusion Criteria

  • Patients with moderate to severe Acne based on global acne grading system criteria
  • Age between 18 and 55 years old

Exclusion Criteria

  • Older than 55 years old
  • Younger than 18 years old
  • Having a contraindication to receiving Botox
  • Having needle phobia
  • Pregnancy and breastfeeding

Investigators

Similar Trials

Efficacy Of Botulinum Toxin In The... | Clinical Trial